Article
BRCA1 and BRCA2 mutation carriers, oral contraceptive use, and breast cancer before age 50.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology - 1 Oct 2006
Haile Robert W, Thomas Duncan C, McGuire Valerie, Felberg Anna, John Esther M, Milne Roger L, Hopper John L, Jenkins Mark A, Levine A Joan, Daly Mary M, Buys Saundra S, Senie Ruby T, Andrulis Irene L, Knight Julia A, Godwin Andrew K, Southey Melissa, McCredie Margaret R E, Giles Graham G, Andrews Lesley, Tucker Katherine, Miron Alexander, Apicella Carmel, Tesoriero Andrea, Bane Anita, Pike Malcolm C, Whittemore Alice S
Abstract excerpt
BACKGROUND: Understanding the effect of oral contraceptives on risk of breast cancer in BRCA1 or BRCA2 mutation carriers is important because oral contraceptive use is a common, modifiable practice. METHODS: We studied 497 BRCA1 and 307 BRCA2 mutation carriers, of whom 195 and 128, respectively,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.